# Waiting for the long in Longevity Aminos

> Longevity Aminos follows a brief hormone pulse into a larger question: how much time do peptide and NAD+ studies actually cover?

**Peptides, aging and elapsed time**

A hormone peaks in minutes. Trials end after weeks or months. The years borrowed by longevity claims are what I’m waiting to see measured.

## Timing a hormone response

In a 1999 study, healthy men received ipamorelin through a vein and researchers watched their blood. Growth hormone rose in [a single pulse, peaking at about 40 minutes](https://pubmed.ncbi.nlm.nih.gov/10496658/). Ipamorelin itself had a terminal half-life of approximately 2 hours. The experiment captured a brief biological event with unusual clarity.

A stopwatch feels like the right instrument for that result. Then I reach the word longevity and the scale changes completely. A hormone response can happen during an afternoon; a claim about healthier later life asks for a much longer account of what followed. This particular study established the pulse and the drug’s movement through blood. It left the later health story unwritten.

[Ipamorelin’s next clinical question](/ipamorelin) was strikingly practical: after bowel surgery, could people tolerate a meal sooner? That [trial missed its primary endpoint](https://pubmed.ncbi.nlm.nih.gov/25331030/). A fast response and a useful recovery turned out to be separate questions.

## Weeks of NAD+ precursor trials

The NAD+ papers move at another pace. In a [60-day NMN trial in middle-aged adults](https://pubmed.ncbi.nlm.nih.gov/36482258/), blood NAD+ rose and walking distance improved compared with placebo. Here something people could do changed alongside a laboratory measure. I’d give that walking test a longer look than another blood measurement.

NMN supplies material for making NAD+; NR does too. These trials tested particular oral ingredients. NAD+ itself is a coenzyme used in energy metabolism and repair, rather than a chain of amino acids. The [NAD+ page](/nad) follows the different trial durations and the different outcomes, including results that stayed unchanged.

## Skin experiments and muscle tests

A [skin penetration experiment ran for 48 hours](https://pmc.ncbi.nlm.nih.gov/articles/PMC3016279/). It tracked copper applied as GHK-Cu in removed human skin. A [hair trial lasted 6 months](https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/) and tested a mixture containing plain GHK. Those are two quite different kinds of time spent with an ingredient. The [GHK-Cu story](/ghk-cu) needs both the formulation and the clock.

[MOTS-c research](/mots-c) brings in age itself: treated old mice performed better in [running, grip and gait tests](https://pubmed.ncbi.nlm.nih.gov/33473109/). Preserving ability is a concrete aging question. The published human findings here follow existing blood levels, while the treatment gains come from animals.

## Human lifespan

None of these studies demonstrated that treating people added years to their lives. Even a longer study would need to measure the relevant health outcome; simply leaving the calendar running would settle very little. A [2025 review of human NAD+ precursor research](https://pubmed.ncbi.nlm.nih.gov/41083806/) found limited efficacy and sparse information about NAD+ inside specific tissues.

The results with a clear beginning and end have the strongest appeal: a measured pulse, a walking test, a particular skin change. The large claim can wait. There is already plenty to investigate in the [durations and outcomes of these studies](/compare), and in the [full reading list](/references).

---

Longevity Aminos is an independent case file on amino-acid signals and aging claims, built from the literature and never offered as a shop or medical counsel.